Johnson & Johnson completes acquisition of Shockwave Medical, Inc. to expand its presence in cardiovascular intervention
Acquiring Company
Johnson & Johnson
Acquired Company
ShockWave Medical
New BrunswickSanta Clara Countyhospital & health careBiotechnologyHealthcareHealth CareMedicalMedical DeviceTherapeuticsDescription
Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire all outstanding shares of Shockwave Medical, Inc. (Nasdaq: SWAV) for $335.00 per share in cash, with a total enterprise value of approximately $13.1 billion. This acquisition will further extend Johnson & Johnson's position in the cardiovascular intervention market, providing an opportunity to accelerate their impact and drive greater value for patients, shareholders, and health systems. Shockwave's IVL technology for treating CAD and PAD, and its strong pipeline, are expected to enhance Johnson & Johnson's leadership position in medtech and expand into additional high-growth segments.
Quick answer
Johnson & Johnson is acquiring ShockWave Medical, announced April 5, 2024. Johnson & Johnson is based in New Brunswick, New Jersey, United States.
- How much did Johnson & Johnson pay for ShockWave Medical?
- The deal value was not disclosed.
- What does Johnson & Johnson do?
- For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation.
- Where are Johnson & Johnson and ShockWave Medical based?
- Johnson & Johnson is based in New Brunswick, New Jersey, United States. ShockWave Medical is based in Santa Clara County, California, United States.
- Who are the decision-makers at Johnson & Johnson?
- Fundz holds 1 contact at Johnson & Johnson. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in hospital & health care and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Harmony Biosciences acquires Epygenix Therapeutics, Inc. to expand rare epilepsy franchise (April 30, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- XOMA Corporation successfully acquires Kinnate Biopharma Inc. (April 3, 2024)
Who to call at Johnson & Johnson, and when
When Johnson & Johnson changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Johnson & Johnson raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Johnson & Johnson, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Johnson & Johnson makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ShockWave Medical?
ShockWave Medical was acquired by Johnson & Johnson, based in New Brunswick. The deal was reported on April 5, 2024. For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation. Learn about the products, people and history that make up our company. Johnson & Johnson is publicly traded (JNJ) and operates in hospital & health care.
When did Johnson & Johnson acquire ShockWave Medical?
Johnson & Johnson's acquisition of ShockWave Medical was reported on April 5, 2024. Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire all outstanding shares of Shockwave Medical, Inc. (Nasdaq: SWAV) for $335.00 per share in cash, with a total enterprise value of approximately $13.1 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ShockWave Medical do?
ShockWave Medical focuses on developing and commercializing intravascular lithotripsy technology used to treat calcified cardiovascular disease. Their innovative systems deliver sonic pressure waves to modify hard calcium deposits in arterial walls. It is privately held, operating in Biotechnology, and is based in Santa Clara County.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.